FDA Broadens Caplyta Approval to Include Major Depression

(MedPage Today) — The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults, Johnson & Johnson announced.
Lumateperone was previously approved as an adjunctive…

Source link : https://www.medpagetoday.com/psychiatry/depression/118356

Author :

Publish date : 2025-11-06 21:18:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

FDA Broadens Caplyta Approval to Include Major Depression

Cancer Drugs, Anti-Obesity Pill Secure FDA Expedited Review Vouchers

Amylin Analog Eloralintide Reduces Weight in Phase 2 Trial

Related Posts

Cringiest Medical Errors; Docs, Nurses Recognize World AIDS Day; Hep B Vaccine PSA

Cognitive Intervention Does More Than Defend Against Dementia

Streeting Orders Review of Mental Health and ADHD Diagnoses

Make the Diagnosis: What Do the Punch Biopsy Findings Suggest?

What I Think Is Really Going on With Trump’s Imaging Tests

Why I Chose to Get E. Coli

Cringiest Medical Errors; Docs, Nurses Recognize World AIDS Day; Hep B Vaccine PSA

Cognitive Intervention Does More Than Defend Against Dementia

Streeting Orders Review of Mental Health and ADHD Diagnoses

Make the Diagnosis: What Do the Punch Biopsy Findings Suggest?

What I Think Is Really Going on With Trump’s Imaging Tests

Why I Chose to Get E. Coli

Celecoxib Benefit Seen in ctDNA-Positive Colon Cancer

Volcano eruption may have led to the Black Death coming to Europe

Categories

Archives